Laboratory Corporation of America Holdings Stock
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
198.4 USD | -4.61% | -0.55% | -12.73% |
Financials (USD)
Sales 2024 * | 12.83B | Sales 2025 * | 13.33B | Capitalization | 16.72B |
---|---|---|---|---|---|
Net income 2024 * | 1B | Net income 2025 * | 1.12B | EV / Sales 2024 * | 1.65 x |
Net Debt 2024 * | 4.42B | Net Debt 2025 * | 3.85B | EV / Sales 2025 * | 1.54 x |
P/E ratio 2024 * |
16.9
x | P/E ratio 2025 * |
15
x | Employees | 61,975 |
Yield 2024 * |
1.5% | Yield 2025 * |
1.54% | Free-Float | 99.66% |
Latest transcript on Laboratory Corporation of America Holdings
1 day | -4.61% | ||
1 week | -0.55% | ||
Current month | -9.21% | ||
1 month | -7.20% | ||
3 months | -12.49% | ||
6 months | +0.33% | ||
Current year | -12.73% |
Managers | Title | Age | Since |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Glenn Eisenberg
DFI | Director of Finance/CFO | 62 | 14-06-15 |
Compliance Officer | 65 | 19-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Williams
BRD | Director/Board Member | 75 | 07-05-15 |
Adam Schechter
CEO | Chief Executive Officer | 59 | 13-03-31 |
Director/Board Member | 74 | 95-04-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.97% | 2 M€ | +5.19% | ||
1.95% | 8 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 198.4 | -4.61% | 2,098,112 |
24-04-24 | 207.9 | -0.01% | 793,528 |
24-04-23 | 208 | +2.41% | 925,458 |
24-04-22 | 203.1 | +0.79% | 685,960 |
24-04-19 | 201.5 | +1.02% | 768,208 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.73% | 16.72B | |
-14.73% | 84.87B | |
+16.05% | 83.08B | |
+10.92% | 29.4B | |
-3.17% | 16.4B | |
-1.78% | 15.04B | |
-0.45% | 11.88B | |
-31.23% | 11.86B | |
-2.51% | 11.88B | |
+26.74% | 11.64B |
- Stock Market
- Equities
- LH Stock